Education
About Us
Working with TipRanks
Follow Us
AnaptysBio Inc (ANAB)
NASDAQ:ANAB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 91.28M | $ 17.16M | $ 10.29M | $ 63.17M | $ 75.00M |
| Gross Profit | $ -72.56M | $ -115.13M | $ -78.51M | $ -35.32M | $ -5.03M |
| Operating Income | $ -114.95M | $ -164.41M | $ -115.15M | $ -56.81M | $ -23.88M |
| EBITDA | $ -92.74M | $ -156.42M | $ -105.26M | $ -55.71M | $ -19.37M |
| Net Income | $ -145.23M | $ -163.62M | $ -128.72M | $ -57.80M | $ -19.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 385.37M | $ 390.90M | $ 441.24M | $ 548.10M | $ 393.65M |
| Total Assets | $ 483.83M | $ 452.39M | $ 610.38M | $ 643.07M | $ 416.55M |
| Total Debt | $ 369.46M | $ 17.81M | $ 19.45M | $ 20.95M | $ 342.00K |
| Net Debt | $ 246.38M | $ -18.15M | $ -51.86M | $ -474.77M | $ -250.11M |
| Total Liabilities | $ 412.97M | $ 364.29M | $ 348.28M | $ 286.64M | $ 19.82M |
| Stockholders' Equity | $ 70.87M | $ 88.10M | $ 262.10M | $ 356.43M | $ 396.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -135.69M | $ -121.61M | $ -73.95M | $ -47.29M | $ -14.73M |
| Operating Cash Flow | $ -135.34M | $ -120.80M | $ -73.59M | $ -45.92M | $ -14.16M |
| Investing Cash Flow | $ 95.40M | $ 144.75M | $ -394.85M | $ 38.84M | $ 94.47M |
| Financing Cash Flow | $ 127.05M | $ -59.30M | $ 44.02M | $ 252.30M | $ -879.00K |